Aurobindo Pharma and Merck Sharpe & Dohme join hands for biological supply
Pharma sector firm Aurobindo Pharma has signed a master service agreement with Merck Sharpe & Dohme Singapore for contract manufacturing of biologicals. The firm's wholly-owned subsidiary TheraNym Biologics Pvt Ltd (TheraNym) has signed the deal. Under the agreement, TheraNym would contract to manufacture biologicals for the domestic and international markets.
TheraNym will also invest Rs 1,000 crore in a biologics manufacturing facility in Telangana. The manufacturing facility would be at Borapatla in Hathnoora mandal of Medak district in Telangana. This facility will have large-scale bioreactors for any mammalian cell culture product and a vial-filling isolator line for commercial drug product manufacturing upto 25-30 million vials annually.
Also Read: Aurobindo Pharma Acquires Veritaz